Acasti Pharma Inc.
ACST
Rang in Aktien
#29802
Acasti Pharma Inc. is a biopharmaceutical company dedicated to the research,... Acasti Pharma Inc. is a biopharmaceutical company dedicated to the research, development, and market introduction of pharmaceutical solutions for cardiovascular conditions. The firm is currently exploring strategic collaborations to further the clinical advancement of its compound, CaPre. Established in 2002, Acasti Pharma Inc. maintains its principal operations from its headquarters in Laval, Canada.
Aktienkurs
$0.41258382
Zuletzt synchronisiert: 2023-03-27
Marktkapitalisierung
$18.41M
Veränderung (1 Tag)
-0.09%
Veränderung (1 Jahr)
-87.42%
Land
CA
Handel Acasti Pharma Inc. (ACST)
Kategorie
Healthcare
Kursverlauf für Acasti Pharma Inc. (ACST)
Höchster Schlusskurs: $3.14 am 2024-11-01
Niedrigster Schlusskurs: $726.00 am 2012-02-01
Niedrigster Schlusskurs: $726.00 am 2012-02-01
Kursverlauf der Aktie von Acasti Pharma Inc. von 2012 bis 2026
Jährliche Kursentwicklung
| Jahr | Leistung |
|---|---|
| 2024 | 34.72% |
| 2023 | -9.30% |
| 2022 | -64.98% |
| 2021 | -48.82% |
| 2020 | -86.25% |
| 2019 | 209.96% |
| 2018 | -47.13% |
| 2017 | 2.86% |
| 2016 | -43.73% |
| 2015 | -54.07% |
| 2014 | -59.53% |
| 2013 | -48.78% |
| 2012 | 0.00% |
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Aktienkurs | Veränderung 1J% | Land |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.17 | -4.24% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
